Connecticut Innovations and Elm Street Ventures Back AxioMx
December 27, 2012
AxioMx, a biotechnology company working to “discover, develop and deliver recombinant antibodies that perform as required,” has raised $2.5 million from Connecticut Innovations, Elm Street Ventures and the company’s founders. The company’s developments are especially useful for life science research, diagnostic tests and therapeutics. AxioMx is based in Bradford, CT.